Market Place
Sourcing Support
Synedgen Announces 2.2M Award for MIIST305 Radiation Countermeasure
31 Oct 2024 //
BUSINESSWIRE
Synedgen Receives BARDA Contract To Develop MIIST305
15 Oct 2024 //
BUSINESSWIRE
Synedgen Adds Dr. Hal J. Oien to its Board of Directors
24 Sep 2024 //
BUSINESSWIRE
Synedgen Completes IND-Enabling Studies for MIIST305 Programs
25 Apr 2024 //
BUSINESSWIRE
Synedgen Initiates Clinical Trial Assessing Combination of SynePure and Catasyn
06 Aug 2021 //
BUSINESSWIRE
Synedgen Initiates Clinical Trial Assessing Combination of SynePure and Catasyn
06 Aug 2021 //
BUSINESSWIRE
Synedgen Receives Supplemental NEI Funding to Identify Lead Development
30 Oct 2020 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.